Citation: D. Vordermark et al., Green fluorescent protein is a suitable reporter of tumor hypoxia despite an oxygen requirement for chromophore formation, NEOPLASIA, 3(6), 2001, pp. 527-534
Authors:
Vordermark, D
Flentje, M
Sailer, M
Kolbl, O
Citation: D. Vordermark et al., Intracavitary afterloading boost in anal canal carcinoma - Results, function and quality of life, STRAH ONKOL, 177(5), 2001, pp. 252-258
Citation: D. Vordermark, Brachytherapy - Results of two different therapy strategies for patients with primary glioblastoma multiforme, CANCER, 91(6), 2001, pp. 1185-1186
Authors:
Vordermark, D
Becker, G
Flentje, M
Richter, S
Goerttler-Krauspe, I
Koelbl, O
Citation: D. Vordermark et al., Transcranial sonography: Integration into target volume definition for glioblastoma multiforme, INT J RAD O, 47(3), 2000, pp. 565-571
Authors:
Bouterfa, HL
Sattelmeyer, V
Czub, S
Vordermark, D
Roosen, K
Tonn, JC
Citation: Hl. Bouterfa et al., Inhibition of Ras farnesylation by lovastatin leads to downregulation of proliferation and migration in primary cultured human glioblastoma cells, ANTICANC R, 20(4), 2000, pp. 2761-2771
Authors:
Vordermark, D
Sailer, M
Flentje, M
Thiede, A
Kolbl, O
Citation: D. Vordermark et al., Curative-intent radiation therapy in anal carcinoma: quality of life and sphincter function, RADIOTH ONC, 52(3), 1999, pp. 239-243